H.R. 901 · 118th Congress · Health

Disposable ENDS Product Enforcement Act of 2023

Died in committee517 words Introduced Feb 9, 2023 · Latest action Feb 17, 2023

How far it has goneStopped at 2 of 6 · Died in committee
  1. IntroducedFeb 9, 2023 Done
  2. CommitteeDied Jan 3, 2025 Stopped here
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill requires the Food and Drug Administration (FDA) to update its enforcement guidance regarding Electronic Nicotine Delivery System (ENDS) products to include certain disposable ENDS products.

In April 2020, the FDA published revised guidance on how it intends to prioritize enforcement resources with respect to ENDS products that do not have premarket authorization (i.e., that have not received FDA approval). The guidance specifies that the FDA intends to prioritize enforcement against (1) flavored, cartridge-based ENDS products (except for tobacco or menthol flavored products); (2) other ENDS products for which the manufacturer has not taken adequate measures to prevent access to minors; (3) any ENDS products that are targeted or promoted towards minors; and (4) any ENDS products for which the manufacturer has not submitted an application for market approval or did not receive approval.

For purposes of this guidance, cartridge-based ENDS products do not include disposable products that are completely self-contained. The bill requires the FDA to incorporate these products, including nicotine products that are not derived from tobacco, into its enforcement priorities. The bill additionally specifies that the FDA may prioritize enforcement against these products in advance of updating the guidance. The FDA must also annually report on its enforcement actions with respect to these products.

Congressional Research Service · summary of “Introduced in House” version · Feb 9, 2023

Who lobbies on it

3 organizations · 61 filings · Q1 2023–Q4 2024

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Rai Services Company 8 of 8 quarters
    “Tobacco product regulation and taxation, excise taxes. H.R. 901”

    Q4 2024 filing · $5.7M lobbying spend in 2024, all issues

  2. Juul Labs Inc 8 of 8 quarters
    “Risk-proportionate regulation for electronic delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products. Issues related to taxation and user fees for tobacco…”

    Q4 2024 filing · $1.1M lobbying spend in 2024, all issues

  3. Altria Client Services Llc 6 of 8 quarters
    “HR 901 Disposable ENDS Product Enforcement Act of 2023; all provisions of the bill HJRes 99 To amend the Federal Food Drug and Cosmetic Act to exempt the premium cigar industry from certain regulations; all provisions of the bill H. Res. 979 Expressing the sense of the House of Representatives that public health…”

    Q4 2024 filing · $13.2M lobbying spend in 2024, all issues

Organizations that named H.R. 901 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

3 actions · newest first
  1. Feb 17, 2023Referred to the Subcommittee on Health.
  2. Feb 9, 2023Referred to the House Committee on Energy and Commerce.
  3. Feb 9, 2023Introduced in House